Safety study of RS-C1001 in healthy Chinese adults
Part of Hormones & metabolism clinical trials.
This study tests a new medication called RS-C1001 in healthy Chinese volunteers to see if it's safe and how the body processes it. The drug may help lower cholesterol, but the main goal here is to check for side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are generally healthy and between 18 and 45 years old.
- Your body mass index (BMI) is between 19 and 26, and you weigh at least 110 pounds (if male) or 99 pounds (if female).
- Your LDL cholesterol is below 159 mg/dL and your triglycerides are below 301 mg/dL.
- You do not smoke more than 5 cigarettes per day and can avoid all smoking during the study.
- You agree to use effective birth control (if female) or have your partner use birth control (if male) for 6 months after the last dose.
- You are not taking any prescription or over-the-counter medications, supplements, or herbal products unless approved by the study doctor.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug called HS-10510 in healthy people to see if it is safe and how the body handles it. It is for healthy adults who meet specific weight and cholesterol levels.
This trial tests a new drug called HS-10582 in healthy people and those with slightly high LDL cholesterol (a type of cholesterol). The goal is to see if it is safe and how well your body handles it.
This trial tests two experimental drugs in healthy adults to see how they interact with each other and to check their safety. It involves taking the drugs in a specific order over multiple days.
This trial tests a new tablet called KPC000154 in healthy people to see if it is safe and how the body handles it. It may help develop a treatment for conditions related to high cholesterol.
This study tests different forms of an experimental medicine called HRS-5346 to see how the body absorbs them. It is for healthy people aged 18 to 45, and the results will help decide which version to use in future studies.
This trial tests a new investigational medicine (SYH2053) for people with high cholesterol or mixed hyperlipidemia who are already on cholesterol-lowering therapy but still have high levels of 'bad cholesterol' (LDL-C). The goal is to see if this add-on treatment can help lower cholesterol further and reduce heart disease risk.
Hear when a new Dyslipidemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.